Commonwealth Numbered ActsRepeal the subsection, substitute:
(a) the therapeutic goods are therapeutic devices; and
(b) the evaluation of the goods for registration has been completed;
the Secretary must:
(c) notify the applicant in writing of his or her
decision on the evaluation within 28 days of the making of the
decision and, in the case of a decision not to register the goods, of
the reasons for the decision; and
(d) if the decision is to register the goodsinclude the goods in the
Register and give the applicant a certificate of registration.
(a) the therapeutic goods are not therapeutic devices; and
(b) the evaluation of the goods for registration has been completed;
the Secretary must:
(c) notify the applicant in writing of his or her
decision on the evaluation within 28 days of the making of the
decision and, in the case of a decision not to register the goods, of
the reasons for the decision; and
(d) if the decision is to register the goods:
(i) notify the applicant in writing that the goods will be included in the
Register if the applicant gives the Secretary the certificate required
under subsection 26B(1); and
(ii) include the goods in the Register and give the applicant a certificate
of registration if the applicant gives the Secretary the certificate
required under subsection 26B(1).
To avoid doubt, if the applicant gives the Secretary the certificate required under subsection 26B(1), the Secretary must include the goods in the Register under subparagraph (d)(ii) without inquiring into the correctness of the certificate.
Insert:
(aa) if goods are not therapeutic devicesthe application is accompanied by the certificate required under subsection 26B(1); and
3 After subsection 26(1)Insert:
(a) an application is made for the listing of therapeutic goods in relation to
a person in accordance with section 23; and
(b) the application is accompanied by the certificate required under
subsection 26B(1); and
(c) the other requirements in subsection (1) are met;
the Secretary must list the goods under subsection (1) without inquiring into the correctness of the certificate.
Insert:
(b) the application is accompanied by the certificate required under subsection 26B(1); and
5 After subsection 26A(1)Insert:
(a) an application is made for the listing of a medicine in relation to a
person in accordance with section 23; and
(b) the application is accompanied by the certificate required under
subsection 26B(1); and
(c) the other requirements in subsection (1) are met;
the Secretary must list the medicine under subsection (1) without inquiring into the correctness of the certificate.
Insert:
26B Certificates required in relation to patents
(a) a certificate to the effect that the applicant, acting in good faith,
believes on reasonable grounds that it is not marketing, and does not propose
to market, the therapeutic goods in a manner, or in circumstances, that would
infringe a valid claim of a patent that has been granted in relation to the
therapeutic goods; or
(b) a certificate to the effect that:
(i) a patent has been granted in relation to the therapeutic goods; and
(ii) the applicant proposes to market the therapeutic goods before the end
of the term of the patent; and
(iii) the applicant has given the patentee notice of the application for
registration or listing of the therapeutic goods under
section 23.
The certificate must be signed by, or on behalf of, the applicant and must be in a form approved by the Secretary.
(a) the person gives a certificate required under subsection (1); and
(b) the certificate is false or misleading in a material particular.
Maximum penalty: 1,000 penalty units.
(a) a person gives a certificate required under subsection 26B(1) in relation
to therapeutic goods; and
(b) another person (the second person ) intends to commence proceedings
under the Patents Act 1990 against the person referred to in paragraph
(1)(a) for infringement of a patent that has been granted in relation
to the therapeutic goods (the proceedings ).
(a) are to be commenced in good faith; and
(b) have reasonable prospects of success; and
(c) will be conducted without unreasonable delay.
The certificate must be signed by, or on behalf of, the second person and must be in a form approved by the Secretary.
(a) the second person had reasonable grounds in all the circumstances known to
the second person, or which ought reasonably to have been known to the second
person (in addition to the fact of grant of the patent), for believing that he
or she would be entitled to be granted final relief by the court against the
person referred to in paragraph (1)(a) for infringement by that person of the
patent; and
(b) the second person had reasonable grounds in all the circumstances
known to the second person, or which ought reasonably to have been
known to the second person (in addition to the fact of grant of the
patent), for believing that each of the claims, in respect of which
infringement is alleged, is valid; and
(c) the proceedings are not otherwise vexatious or unreasonably pursued.
(a) the certificate is false or misleading in a material particular; or
(b) the second person breaches an undertaking given in the certificate.
Maximum penalty: $10,000,000.
(a) any profit obtained by the second person; and
(b) any loss or damage suffered by any person;
by reason of the second person exploiting the patent during the proceedings.
(a) the second person has sought and obtained in the proceedings an
interlocutory injunction restraining the person referred to in paragraph
(1)(a) from infringing a patent; and
(b) section 26D does not apply; and
(c) a prescribed court declares that the second person has given a
certificate required under subsection (3); and
(d) a prescribed court declares that:
(i) the certificate is false or misleading in a material particular; or
(ii) the second person has breached an undertaking given in the
certificate;
the prescribed court may, pursuant to this section, order that the second person pay to the Commonwealth, a State or a Territory compensation for any damages sustained or costs incurred by the Commonwealth, a State or a Territory as a result of the grant of the interlocutory injunction.
(a) an applicant gives notice to a patentee in accordance with subparagraph
26B(1)(b)(iii); and
(b) the patentee and/or its exclusive licensee (in this section the party
or parties is or are referred to as the patentee ) applies to a
prescribed court for an interlocutory injunction to restrain the
applicant from marketing the therapeutic goods the subject of the
application on the ground that such conduct will constitute an
infringement of its patent.
(a) the patentee subsequently discontinues the principal proceedings without
the consent of the other parties thereto; or
(b) the principal proceedings are dismissed; and
(c) in either case, the prescribed court declares that:
(i) the patentee did not have reasonable grounds, in all the circumstances
known to the patentee or which ought reasonably have been known to the
patentee:
(A) to believe that it would be granted final relief by the
prescribed court against the applicant referred to in
paragraph (1)(a) for infringement by that person of the
patent; or
(B) (in addition to the fact of grant of the patent), for
believing that each of the claims, in respect of which
infringement is alleged in the proceedings, would have a
reasonable prospect of being held to be valid if
challenged by the applicant referred to in paragraph
(1)(a); or
(ii) the application for the interlocutory injunction was otherwise
vexatious or not reasonably made or pursued;
the prescribed court may, in addition to any other relief which it believes should be granted to any person, make any of the orders described in subsection (5).
(a) assess and award compensation to the applicant referred to in paragraph
(1)(a) against whom the interlocutory injunction was made:
(i) on the basis of an account of the gross profits of the patentee
arising from the sale by it in Australia of the therapeutic goods the
subject of the interlocutory injunction, during the period of the
interlocutory injunction, without requiring the said applicant to
establish or quantify its actual loss; or
(ii) on such other basis as the court determines to be appropriate; and
(b) award to the Commonwealth compensation for any damages sustained, or
costs incurred, by it as a result of the grant of the interlocutory
injunction; and
(c) award to a State or a Territory compensation for any damages
sustained, or costs incurred, by it as a result of the grant of the
interlocutory injunction.
(1) The amendments made by this Schedule apply to
applications for registration or listing under section 23 of the
Therapeutic Goods Act 1989 made on or after the day on which this Schedule
commences.
(2) The amendments made by item 6 apply to legal proceedings
commenced on or after the day on which this Schedule commences.